Results 281 to 290 of about 5,120,899 (402)

The validation of a simple and instrument-free technique to measure the depth of the natal cleft (a cohort study). [PDF]

Colorectal Dis
Ojo D, Bassett P, Thomas G, Senapati A.
europepmc   +1 more source

Interplay of integrins and selectins in metastasis

Molecular Oncology, EarlyView.
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva, Ashot Nersisyan, Alexander Tonevitsky   +2 more
wiley   +1 more source

Design and Implementation of the Luenberger Observer for Estimating the Voltage Response of a PEM Electrolyzer During Supply Current Variations [PDF]

Ángel Hernández-Gómez, Diego Langarica-Córdoba, Pánfilo R. Martínez-Rodríguez, Hernàn González-Aguilar, Damien Guilbert, Belem Saldivar   +5 more
openalex   +1 more source

Human V4 size predicts crowding distance. [PDF]

Nat Commun
Kurzawski JW, Qiu BS, Majaj NJ, Benson NC, Pelli DG, Winawer J.   +5 more
europepmc   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Event‐Triggered Generalized Extended State Observer‐Based Control for Nonlinear Networked Systems Under Gain Variation and Multi‐Channel Attacks [PDF]

Pengcheng Zhang, Jianyu Wang, Yajuan Liu, Sangmoon Lee   +3 more
openalex   +1 more source

Inter- and intra-observer variability of software quantified bowel motility measurements of small bowel Crohn's disease: findings from the MOTILITY trial. [PDF]

Insights Imaging
Hameed M, Plumb AA, Chowdhury K, Ahmed N, Rahman S, Bhatnagar G, Thomson E, Mohsin M, Holmes J, Halligan S, Taylor SA, MOTILITY trial investigators.   +11 more
europepmc   +1 more source

Observer variation in drug-induced sleep endoscopy: experienced versus nonexperienced ear, nose, and throat surgeons. [PDF]

Sleep, 2013
Vroegop AV, Vanderveken OM, Wouters K, Hamans E, Dieltjens M, Michels NR, Hohenhorst W, Kezirian EJ, Kotecha BT, de Vries N, Braem MJ, Van de Heyning PH.   +11 more
europepmc   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Observer- and sequence variability in personalized 4D flow MRI-based cardiovascular models. [PDF]

Sci Rep
Casas Garcia B, Tunedal K, Viola F, Cedersund G, Carlhäll CJ, Karlsson M, Ebbers T.   +6 more
europepmc   +1 more source